(S)-2,6-Diamino-N-(3-((4-((3-aminopropyl)amino)butyl)-amino)propyl)hexanamide pentahydrochloride

ID: ALA3127367

Chembl Id: CHEMBL3127367

PubChem CID: 76321960

Max Phase: Preclinical

Molecular Formula: C16H39ClN6O

Molecular Weight: 330.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.NCCCC[C@H](N)C(=O)NCCCNCCCCNCCCN

Standard InChI:  InChI=1S/C16H38N6O.ClH/c17-8-2-1-7-15(19)16(23)22-14-6-13-21-11-4-3-10-20-12-5-9-18;/h15,20-21H,1-14,17-19H2,(H,22,23);1H/t15-;/m0./s1

Standard InChI Key:  STXCGVQJROOTFC-RSAXXLAASA-N

Associated Targets(non-human)

CHO-MG (239 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 330.52Molecular Weight (Monoisotopic): 330.3107AlogP: -0.74#Rotatable Bonds: 17
Polar Surface Area: 131.22Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 9#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.89CX LogP: -2.12CX LogD: -12.31
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.19Np Likeness Score: 0.20

References

1. Muth A, Madan M, Archer JJ, Ocampo N, Rodriguez L, Phanstiel O..  (2014)  Polyamine transport inhibitors: design, synthesis, and combination therapies with difluoromethylornithine.,  57  (2): [PMID:24405276] [10.1021/jm401174a]

Source